Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Cancer    crawled date : 2022 - 02 - 24    save search

EPIC SCIENCES AND FULGENT GENETICS COLLABORATE TO DELIVER DefineMBC™ RESULTS FOR METASTATIC BREAST CANCER PATIENTS
Published: 2022-02-24 (Crawled : 19:00) - biospace.com/
FLGT | $20.75 0.53% 0.53% 150K twitter stocktwits trandingview |
Health Services
| | O: -9.56% H: 0.0% C: 0.0%

genetic liver results cancer breast cancer collaboration metastatic breast cancer
Gun Maker Donates 55 Rifles for 4-Year-Old Girl's Kidney Cancer Treatments
Published: 2022-02-24 (Crawled : 15:30) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| | O: -2.2% H: 0.0% C: -0.14%

treatment kidney cancer
PDS Biotech Announces Preliminary Safety Data on PDS0101 in Combination With KEYTRUDA® (pembrolizumab) at the 2022 Multidisciplinary Head and Neck Cancers Symposium
Published: 2022-02-24 (Crawled : 15:30) - globenewswire.com
PDSB | $3.26 1.88% 1.84% 450K twitter stocktwits trandingview |
Health Technology
| | O: -7.03% H: 14.74% C: 13.42%

pds0101 keytruda symposium cancer head and neck biotech iot
Global Roundup: NuCana's Biliary Tract Cancer Drug, Charles River, Noema and More
Published: 2022-02-24 (Crawled : 15:00) - biospace.com/
NCNA | $3.84 -4.0% -4.17% 12K twitter stocktwits trandingview |
Health Technology
| | O: -8.3% H: 10.24% C: 8.66%

ema drug cancer drug cancer
Global Roundup: NuCana's Biliary Tract Cancer Drug, Charles River, Noema and ...
Published: 2022-02-24 (Crawled : 14:30) - biospace.com/
NCNA | $3.84 -4.0% -4.17% 12K twitter stocktwits trandingview |
Health Technology
| | O: -8.3% H: 10.24% C: 8.66%

ema drug cancer drug cancer
Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer
Published: 2022-02-24 (Crawled : 06:00) - prnewswire.com
GTHX | $3.98 -5.01% -5.28% 340K twitter stocktwits trandingview |
Health Technology
| | O: -12.4% H: 28.19% C: 28.19%

chinese trilaciclib trial cel lung cancer cancer
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.